new-pharma300x111.jpg
Informa Pharma Intelligence Launches Citeline Study Feasibility to Accelerate Clinical Trial Timelines
June 16, 2021 09:00 ET | Informa Business Intelligence
NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today announced the launch of Citeline Study...
Sunshine Biopharma Logo
Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned
June 09, 2021 09:00 ET | Sunshine Biopharma Inc.
MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Unified Platforms: Rethinking Trial Planning and Execution" at Outsourcing in Clinical Trials UK & Ireland 2021
June 08, 2021 09:45 ET | Axiom Real-Time Metrics Inc
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
PDS Biotech Logo.png
PDS Biotechnology Set to Join Russell Microcap® Index
June 07, 2021 08:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
SPNGNX_logo_hrz.jpg
Spinogenix Granted FDA Orphan Drug Designation for SPG302 for the Treatment of Amyotrophic Lateral Sclerosis
June 07, 2021 07:00 ET | Spinogenix, Inc.
SAN DIEGO, June 07, 2021 (GLOBE NEWSWIRE) -- Spinogenix, Inc. a pharmaceutical company focused on the development of novel synaptogenic small molecule therapies for central nervous system disorders...
22157.jpg
Global Clinical Trials Market Analysis Report 2021: Phase III Clinical Trials Dominated the Market with a Share of 53.2% in 2020 - Forecast to 2028
June 04, 2021 07:33 ET | Research and Markets
Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional,...
new-pharma300x111.jpg
While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy
June 03, 2021 13:21 ET | Informa Business Intelligence
NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, released its “Q2 2021 Clinical Trials and the COVID-19...
PDS Biotech Logo.png
PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
June 03, 2021 08:53 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., June 03, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Unified Platforms: Key Modules and Data Considerations for Study Success" at eClinical & Clinical Data Management Innovation Conference
June 02, 2021 09:36 ET | Axiom Real-Time Metrics Inc
TORONTO, June 02, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
NOVARTIS logo.jpg
Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
June 02, 2021 01:15 ET | Novartis Pharma AG
Phase III JUNIPERA study met its primary endpoint, with Cosentyx® (secukinumab) showing significantly longer time to flare (longer time to worsening of symptoms1) vs. placebo (P<.001) in pediatric...